Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
Title:
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
Author:
Piemonti, Lorenzo Landoni, Giovanni Voza, Antonio Puoti, Massimo Gentile, Ivan Coppola, Nicola Nava, Stefano Mattei, Alessia Marinangeli, Franco Marchetti, Giulia Bonfanti, Paolo Mastroianni, Claudio Maria Bassetti, Matteo Crisafulli, Ernesto Grossi, Paolo Antonio Zangrillo, Alberto Desai, Antonio Merli, Marco Foggia, Maria Carpano, Marco Schiavoni, Lorenzo D’Arminio Monforte, Antonella Bisi, Luca Russo, Gianluca Busti, Fabiana Rovelli, Cristina Perrotta, Elisabetta Goisis, Giovanni Gavioli, Elizabeth M. Toya, Sophie De Pizzol, Maria Mantelli, Flavio Allegretti, Marcello Minnella, Enrico Maria